According to the latest report by IMARC Group, titled “Amniotic Membrane Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, the global amniotic membrane market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 10% during 2021-2026.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Request Free Report Sample: https://www.imarcgroup.com/amniotic-membrane-market/requestsample
The amniotic membrane (AM) refers to the innermost layer of the placenta that comprises of an epithelial monolayer, acellular intermediate basement, and an outer mesenchymal cell layer. It surrounds the embryo/fetus and delimits the amniotic cavity, which is filled with amniotic liquid and assists in healing wounds and protecting against infection. Amniotic membranes have various properties, such as anti-inflammatory, anti-bacterial, anti-viral, immunological, anti-angiogenic, proapoptotic, etc. As they interfere with tumor growth by preventing the delivery of nutrients and oxygen to cancer cells, AMs also find various applications in the field of oncology.
The growing number of corneal surgeries due to their ability to reduce pain, improve the appearance of a diseased or damaged cornea, restore vision, etc., represents one of the key factors driving the amniotic membrane market. AMs also assist in enhancing epithelialization, maintaining epithelial phenotype, reinforcing adhesion of basal epithelial cells, etc. Furthermore, AMs are relatively cost-effective as compared to allografts and xenografts and find extensive applications in cosmetic and reconstructive surgeries. Additionally, the increasing investments in research and development (R&D) activities in the field of stem cell and regenerative are also augmenting the market growth. Besides this, rising placenta donations and the escalating demand for tissue-based products for treating surgical wounds will continue to bolster the amniotic membrane market.
Amniotic Membrane Market 2021-2026 Competitive Analysis and Segmentation:
Competitive Landscape With Key Players:
The competitive landscape of the global amniotic membrane market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of these key players include:
- Amnio Technology LLC
- Amniox Medical Inc. (TissueTech Inc.)
- Genesis Biologics
- Human Regenerative Technologies LLC
- Integra LifeSciences Holdings Corporation
- Katena Products Inc.
- MiMedx Group
- Next Biosciences
- Skye Biologics Holdings LLC
- Smith & Nephew plc
- Surgenex LLC
- Ventris Medical LLC
- Wright Medical Group N.V. (Stryker B.V.)
Key Market Segmentation:
The report has segmented the global amniotic membrane market on the basis of product, application, end user and region.
Breakup by Product:
- Cryopreserved Amniotic Membrane
- Lyophilization Amniotic Membrane
Breakup by Application:
- Surgical Wounds
- Ophthalmology
- Others
Breakup by End User:
- Hospitals
- Ambulatory Surgical Centers
- Specialized Clinics
- Research Centers and Laboratory
Breakup by Region:
- North America
- Asia-Pacific
- Europe
- Latin America
- Middle East and Africa
Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/amniotic-membrane-market
Key highlights of the report:
- Market Performance (2015-2020)
- Market Outlook (2021-2026)
- Industry Trends
- Market Drivers and Success Factors
- The Impact of COVID-19 on the Global Market
- Value Chain Analysis
- Structure of the Global Market
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us
IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas: – +1 631 791 1145 | Africa and Europe: – +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
